This website is intended for healthcare professionals only

Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the summer 2026 issue of touchREVIEWS in Endocrinology. In this issue, we bring together articles that reflect the evolving complexity of endocrine and metabolic disease, while highlighting the growing importance of patient-centred care, translational science and interdisciplinary management. We open the issue with a timely commentary by Huajing Ni et al., which examines […]

Welcoming Dr Ahmed Iqbal to the Editorial Board of touchREVIEWS in Endocrinology

2 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Apr 21st 2026

We are pleased to announce that Dr Ahmed Iqbal has joined the Editorial Board of touchREVIEWS in Endocrinology, further strengthening the journal’s expertise in diabetes and metabolic disorders.

Dr Iqbal is a Senior Clinical Lecturer and Honorary Consultant in Diabetes and Endocrinology at the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. He is an internationally recognized clinician–scientist specializing in hypoglycemia, with a strong track record in translational research and patient-centred care.

His research has been supported by leading funding organizations, including the Medical Research Council and the US National Institutes of Health. He has authored the hypoglycemia chapter in the Textbook of Diabetes and published extensively in high-impact, peer-reviewed journals, contributing to advances in diabetes management and outcomes.

Dr Iqbal is also an active member of national committees for Diabetes UK and the Association of British Clinical Diabetologists (ABCD), where he contributes to shaping clinical practice and policy. His work reflects a strong commitment to personalized diabetes care and improving outcomes for people living with diabetes.

Read a recent Q&A with Dr Iqbal on tirzepatide as an adjunctive therapy in people with type 1 diabetes and obesity, which was conducted as part of our coverage of EASD 2025.

The addition of Dr Iqbal to the Editorial Board underscores touchREVIEWS in Endocrinology’s commitment to publishing high-quality, clinically relevant content in endocrinology and diabetes.

We are delighted to welcome Dr Iqbal and look forward to his valuable contributions to the journal’s continued growth and global impact.

More content in diabetes.

Cite: Welcoming Dr Ahmed Iqbal to the Editorial Board of touchREVIEWS in Endocrinology. touchENDOCRINOLOGY. April 21, 2026.

Editor: Carla Junkier, Editorial Director.

Disclosures: This article was created by the touchENDOCRINOLOGY team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.


SIGN UP to touchENDOCRINOLOGY!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup